Showing results (1-10 of 114) with videos related to
Sort By:
Pageof 12
Frontiers in Immunology|January 15, 2013
Novel immune modulators used in hematology: impact on NK cellsStephanie Krieg, Evelyn UllrichFrontiers in Immunology|January 24, 2022
T Helper Cell Lineage-Defining Transcription Factors: Potent Targets for Specific GVHD Therapy?Julia Campe, Evelyn UllrichGene Therapy|March 23, 2021
Current status and perspective of CAR-T and CAR-NK cell therapy trials in GermanyNawid Albinger, Jessica Hartmann, Evelyn UllrichJournal of Leukocyte Biology|July 4, 2023
Nonviral technologies can pave the way for CAR-NK cell therapyTobias Bexte, Lisa Marie Reindl, Evelyn UllrichJournal of Visualized Experiments : Jove|November 15, 2016
Flow Cytometry-based Assay for the Monitoring of NK Cell FunctionsSara Tognarelli, Benedikt Jacobs, Nina Staiger, et al.Frontiers in Immunology|October 9, 2023
Epigenetic targeting to enhance acute myeloid leukemia-directed immunotherapyJohanna Rausch, Evelyn Ullrich, Michael W M KühnOncoimmunology|December 20, 2013
New prospects on the NKG2D/NKG2DL system for oncologyEvelyn Ullrich, Joachim Koch, Adelheid Cerwenka, et al.Frontiers in Immunology|December 22, 2025
Engineering with care: safety assessment platforms for CRISPR-modified natural killer cellsAlieh Fazeli, Evelyn Ullrich, Toni Cathomen, et al.Oncotarget|May 15, 2018
Natural killer cells as a therapeutic tool for infectious diseases - current status and future perspectivesStanislaw Schmidt, Lars Tramsen, Bushra Rais, et al.Oncology Letters|July 12, 2017
Sunitinib does not impair natural killer cell function in patients with renal cell carcinomaJennifer Moeckel, Nina Staiger, Andreas Mackensen, et al.Pageof 12